Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on PYC Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Imugene joins forces with Merck and Pfizer for Phase 2 trial on gastric cancer
News
Last Orders: Tech blooms, but materials & energy drags the ASX down
News
Market highlights and 5 ASX small caps to watch on Tuesday
Director Trades
The most noteworthy directors’ trades on the ASX in 2020
Director Trades
Directors’ Trades: Lots of multi-million dollar trades, but this $15m plunge took the cake
Health & Biotech
ScoPo’s powerplays: It’s been ‘like a waterfall of information’ hitting us daily
News
Rise and Shine: What you need to know before the ASX opens
Director Trades
Directors Trades: Upping the ante with $20m now in the game
Health & Biotech
Health: Opthea’s taking its successful anti-AMD drug to a 1,320 patient phase III trial; raises $50m
Health & Biotech
Dr Boreham’s Crucible: Can Phylogica finally make magic happen after nearly 15 years of trying?
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: EMVision has built its portable brain scanner, trial to begin imminently
Health & Biotech
Health: Zelda wants to buy a private US-based medicinal cannabis company
News
Rise & Shine: What you need to know before the ASX opens
Health & Biotech
Health: PainChek expands into Singapore with landmark deal
Health & Biotech
Phylogica shows its vaccine could cure the dreaded herpes disease
Health & Biotech
